title: [Effect of the DiabetIMSS program on cardiovascular risk, blood pressure and HDL cholesterol in patients with metabolic syndrome].
abstract: OBJECTIVE
  The aim of this paper is to evaluate the effect of the DiabetIMSS program on cardiovascular risk, blood pressure and HDL cholesterol in patients with metabolic syndrome.
  
  
  METHODS
  Quasi-experimental intervention study. Non-probabilistic convenience sampling. 35 subjects in the educational strategy one year were included. The following variables were collected: age, gender, smoking, total cholesterol, HDL cholesterol, systolic and diastolic blood pressure; cardiovascular risk calculator based on Framingham is calculated. Descriptive and inferential statistical percentages with Student t test was used.
  
  
  RESULTS
  There was an increase in the proportion of subjects increased their subsequent figures HDL cholesterol intervention, there by generating an increase of protective factor (p < 0.05). Because of the blood pressure a marked improvement in all ranges of blood pressure (p < 0.05) was presented.
  
  
  CONCLUSIONS
  The educational strategy for the control of diabetic patients presented a favorable performance in HDL-cholesterol and blood pressure, reducing the risk of cardiovascular patients.
authors.affiliation: Coordinación Auxiliar de Investigación en Salud, Instituto Mexicano del Seguro Social, San Luis Potosí, San Luis Potosí, México. miguel.mendozaro@imss.gob.mx.
authors.forename: Miguel Angel
authors.initials: MA
authors.lastname: Mendoza-Romo
authors.forename: Juan Felipe
authors.initials: JF
authors.lastname: Montes-Acuña
authors.forename: Gad Gamed
authors.initials: GG
authors.lastname: Zavala-Cruz
authors.forename: Rafael Natividad
authors.initials: RN
authors.lastname: Nieva-de Jesús
authors.forename: María Cleofas
authors.initials: MC
authors.lastname: Ramírez-Arreola
authors.forename: Héctor Jesús
authors.initials: HJ
authors.lastname: Andrade-Rodríguez
mesh_terms: D000328:Adult; D000368:Aged; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D008076:Cholesterol, HDL; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006293:Health Promotion / Q000379:methods*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D008076:Cholesterol, HDL
keywords: Cardiovascular diseases; Metabolic diseases; Metabolic syndrome X; Type 2 diabetes mellitus